Clinical Trials Browser

Phase 2 × Bone Neoplasms × lenvatinib × Clear all

NCT07619950 2026-06-02

EVERolimus and LenvAtinib Versus Everolimus for Bone Sarcoma

Phase 2 Not yet recruiting

Bone Neoplasms